GSK kicks off global transparency campaign in AustraliaBMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d2792 (Published 03 May 2011) Cite this as: BMJ 2011;342:d2792
- Melissa Sweet
As part of the global drive by GlaxoSmithKline (GSK) to improve transparency in relations with healthcare professionals, the company’s Australian arm will work towards publicly declaring how much it pays individual doctors and other healthcare professionals.
In a first step in this direction GSK has announced that it will declare total payments that it makes to healthcare professionals in Australia, starting with the release next month of 2010 data for all grants, donations, sponsorships, and consultancy fees.
“We will be the first pharmaceutical company in Australia to disclose a total amount of payments made to healthcare professionals,” said Deborah Waterhouse, the general manager of GlaxoSmithKline Australia, in a statement.
“We see this as a critical important step at the start of an era for pharmaceutical companies where …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial